BSNL.SJ
Latest Trade
15.85BAMChange
0.00(0.00%)Volume
400Today's Range
-
15.8552 Week Range
-
19.20As of on the Sarajevo Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 15.85 |
|---|---|
Open | 15.85 |
Volume | 400 |
3M AVG Volume | 0.00 |
Today's High | 15.85 |
Today's Low | 15.85 |
52 Week High | 19.20 |
52 Week Low | 14.04 |
Shares Out (MIL) | 9.04 |
Market Cap (MIL) | 136.25 |
Forward P/E | -- |
Dividend (Yield %) | 3.72 |
Bosnalijek dd Sarajevo Pays Dividend for FY 2012
Bosnalijek dd Sarajevo Appoints New Auditor for FY 2012
Bosnalijek dd Sarajevo Appoints New CEO and Auditor for FY 2012
Bosnalijek dd Sarajevo is a Bosnia and Herzegovina-based company principally engaged in the pharmaceutical and chemical industry. The Company is an international manufacturer of drugs, disinfecting agents and food supplements for prevention, diagnostics and therapy, to maintain public health and to improve quality of life. Its pharmaceutical program includes numerous products based on different generic names for peroral, parenteral, and topical administration with effect on intestinal system and metabolism, cardiovascular system, systemic infections, skin, skeletomuscular system, nervous and respiratory system, as well as systemic hormone drugs with the exception of sex hormones. Bosnalijek dd Sarajevo operates its own development center, which comprises a number of laboratories and a library.
Industry
Biotechnology & Drugs
Executive Leadership
Edin Dizdar
Chairman of the Supervisory Board
Nedim Uzunovic
Chief Executive Officer, Member of the Management Board
Adnan Hadzic
Acting Executive Director for Finance, Member of the Management Board
Mirela Spahic
Acting Executive Director for Operations, Member of the Management Board
Razija Peco
Acting Executive Director for Administration, Member of the Management Board
Price To Earnings (TTM) | 15.06 |
|---|---|
Price To Sales (TTM) | 1.00 |
Price To Book (MRQ) | 0.75 |
Price To Cash Flow (TTM) | 6.28 |
Total Debt To Equity (MRQ) | 48.93 |
LT Debt To Equity (MRQ) | 12.38 |
Return on Investment (TTM) | 3.61 |
Return on Equity (TTM) | 2.66 |
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.